相关实验视频

Updated: May 12, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

IKZF1作为IgA脏病中树突细胞介导免疫疗法的潜在治疗点

Fei Peng^1,2, Chunjia Sheng², Jiayi He³

¹School of Medicine, Nankai University, Tianjin, 300071, China.

Cell communication and signaling : CCS

|May 7, 2025

概括

这项研究确定IKZF1是免疫球蛋白A脏病 (IgAN) 发病的一个关键基因,强调其在树突细胞 (DC) 免疫反应中的作用以及作为IgAN的诊断和治疗点的潜力.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

免疫球蛋白A脏病 (IgAN) 是全球功能衰竭的主要原因.
免疫系统的调节失调是IgAN病原体的核心.
识别新的遗传点对于IGAN诊断和治疗至关重要.

研究的目的:

为了确定参与IgAN免疫失调的新型基因.
阐明树突细胞 (DCs) 在Igan病变发生中的作用.
发现IGAN的潜在诊断生物标志物和治疗点.

主要方法:

权重基因共同表达网络分析 (WGCNA) 和蛋白质-蛋白质相互作用 (PPI) 分析以确定枢纽基因.
机器学习和ROC曲线分析用于生物标志物选.
在体内和体外实验以验证发现并评估治疗干预措施.

主要成果:

IKZF1,MPEG1,CCR2,CCR5和CCR7被确定为与Igan中DC免疫相关的枢纽基因.
证实IKZF1是DC相关免疫反应的关键诊断生物标志物.
IKZF1在DC中促进炎症和抗原呈现;莱纳利多米德治疗减轻了这些影响,并在体内减少了损伤.

结论:

在IgAN中阐明了关键的免疫细胞透模式.
IKZF1被确定为DC驱动的IGAN病变发生的关键因素.
向IKZF1+ DCs为Igan提供了一个有希望的治疗策略.

关键词:

生物标志物生物标志物计算生物学是一种计算生物学.树突性细胞树突性细胞在 IKZF1 免疫球蛋白A 脏病发作

更多相关视频

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...